IHD06N60RA INFINEON | Alldatasheet
Document overview
- Manufacturer or author: Provided By ALLDATASHEET.COM(FREE DATASHEET DOWNLOAD SITE)
- PDF pages: 12
Technical content
Reverse conducting IGBT with monolithic body diode
- Powerful monolithic body diode with low forward voltage designed for soft commutation only
- TrenchStop ® technology applications offers: - very tight parameter distribution - high ruggedness, temperature stable behavior - low V CEsat - easy parallel switching capability due to positive temperature coefficient in V CEsat
- Low EMI
- Qualified according to JEDEC for target applications
- Pb-free lead plating; RoHS compliant; solder temperature 260°C, MSL3
- Complete product spectrum and PSpice Models: http://www.infineon.com/igbt/ G C E *+ ,-, . , ,. , * ,-, . (/ Maximum ratings Parameter Symbol Value Unit 122)31# 4%33#123"' , /"3 4%33#123"' @ A 6 D 6 D 3H I9 (1>#7%99%"3%1& K M N M N Q .S (/
Parameter Symbol Conditions Max. Value Unit Characteristic L5&)3%1& )"9 UV WXK L5&)3%1& )"9 UVY WXK L5&)3%1& "48%&3 UVZ (/ WXK 51& T L5&)3%1& "48%&3 UVZ (/ WXK R2)3#%)"2 Value min. typ. max. Parameter Symbol Conditions Unit Static Characteristic 122)31# 122)31# 6 , . M @ 6 ?, . /"3 4.6 @ M M , 6 @ M /"3 B R2)3#%)"2 Value min. typ. max. Parameter Symbol Conditions Unit Dynamic Characteristic 05353)"")%3"&) J c 6 @ 6=!*d e /"3)C"#' f@g M 6 , .6 M 4"95#7 44P %&S=#14 )"9 h (/
B>%3)C%&' B>%3)C%&' B>%3)C%&' B>%3)C%&' Value min. typ. max. Parameter Symbol Conditions Unit IGBT Characteristic 5#& 1==72"3%4 3iJ__ e"223%4 3_ M 5#& 1==&#' RJ__ M 6 , .6 @ X b6 hj, &*6 jM e hj6 j=#14e%'R B>%3)C%&' B>%3)C%&' B>%3)C%&' B>%3)C%&' Value min. typ. max. Parameter Symbol Conditions Unit IGBT Characteristic 5#& 1==72"3%4 3iJ__ e"223%4 3_ 5#& 1==&#' RJ__ M 6 , .6 @ X b6 hj, &*6 jM e hj6 j=#14e%'R
6 M 6 @
=6BK *-/eRflR- mn*do 0hhR lR-n.o 1E+4 1E+5 1E+6 0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 P+ 6 6 D p @ S 0hhR R!R0h./Rno 0hhR lR-n.o 1 10 100 1000 0.1 3:I9 PD S .BRR!(R.lRn o (J6(0KR+BB(.0-nKo 25 50 75 100 125 150 175 100 e%'5#M e%'5#M e%'5#M e%'5#M P@G 6 D S .BRR!(R.lRn o 0hhR lR-n.o 25 50 75 100 125 150 175
e%'5# e%'5# e%'5# e%'5# P S 0hhR R!R0h./Rno 0hhR lR-n.o 0 1 2 3 4 5 6 P S 0hhR R!R0h./Rno 0hhR lR-n.o 0 1 2 3 4 5 6 e%'5# e%'5# e%'5# e%'5# P S @6/.R R!R0h./Rno 0hhR lR-n.o 2 4 6 8 10 12 e%'5# e%'5# e%'5# e%'5# %)"2)122)31# S 6Ql- 0-R!(R.lRn o 0hhR R!RB.l.0-n.o -50 -25 0 25 50 75 100 125 150 175 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
e%'5# e%'5# e%'5# e%'5# P%&75)3%21"76
6 M 6
X 6 @M b6+&"4%)393)%#)5%3 %&e%'5#RS 0hhR lR-n.o 36BK *-/!RBn&9o 2 4 6 8 10 12 100 1000 3iJ__ P%&75)3%21"76 e%'5#RS @6/.RRBB0nbo 36BK *-/!RBn&9o 0 10 20 30 40 50 60 70 100 1000 3iJ__ X 6 ,.6 @M e%'5#RS @6Ql- 0-R!(R.lRn o 36BK *-/!RBn&9o 25 50 75 100 125 150 175 100 1000 3iJ__ P 4.S @6Ql- 0-R!(R.lRn o @U6/.R R!R*RB*0h+0h./Rno -50 -25 0 25 50 75 100 125 150 175
P%&75)3%21"76 X 6 @M b6+&"4%)393 )%#)5%3%&e%'5#RS 0hhR lR-n.o R6BK *-/R-R/mh0BBRBn4Qo 0 3 6 9 12 15 0.0 0.1 0.2 0.3 0.4 RJ__ P%&75)3%21"76 X 6 @M b6+&"4%)393 )%#)5%3%&e%'5#RS @6/.RRBB0nbo R6BK *-/R-R/mh0BBRBn4Qo 0 10 20 30 40 50 60 70 0.0 0.1 0.2 0.3 0.4 RJ__ e%'5# e%'5# e%'5# e%'5# X 6 ,.6 @M e%'5#RS 6Ql- 0-R!(R.lRn o R6BK *-/R-R/mh0BBRBn4Qo 0 25 50 75 100 125 150 175 0.0 0.1 0.2 0.3 0.4 RJ__ P%&75)3%21"76 6 @ X 6 ,.6 @M e%'5#RS 0hhR R!R0h./Rno R6BK *-/R-R/mh0BBRBn4Qo 200 300 400 500 600 0.0 0.1 0.2 0.3 0.4 RJ__
e%'5# e%'5# e%'5# e%'5# P,.S f@6/.R *./Rn& o @6/.R R!R0h./Rno 0 10 20 30 40 50 M e%'5# e%'5# e%'5# e%'5# )122)31# 4%33#123"' P@ 6=!*dS 0hhR R!R0h./Rno .(. Rneo 0 5 10 15 20 25 30 100 1000 J c e%'5# e%'5# e%'5# e%'5# 1='"3 4%33#123"' 1='"3 4%33#123"' 1='"3 4%33#123"' 1='"3 4%33#123"' PD 693"#3"3 D S @6/.R R!R0h./Rno 3H6B*0 lK*B.-+!RnI9o 10 12 14 16 18 20 P+3:XS 3:6(lhBRK+*n9o ^UV6.-BR-*R!.hRBB.- RnWXKo 1E-6 1E-5 1E-4 0.001 0.01 0.1 1 0.01 0.1 9%&'2529 #\nWXKoF \n9oF M M R R M M M R M M
P+3:XS 3:6(lhBRK+*n9o ^UV6.-BR-*R!.hRBB.- RnWXKo 1E-6 1E-5 1E-4 0.001 0.01 0.1 1 0.01 0.1 9%&'2529 #\nWXKoF \n9oF M M R R M M M R M M ?6e0K.+0h./Rno ?6e0K.+ lR-n.o 0 1 2 3 4 6l@ 6l@ 6l@M 6l@ 6l@, 6l@ 6l@ 6l@ 6l@ 6l@ 6l@, 6Ql- 0-R!(R.lRn o ?6e0K.+0h./Rno 25 50 75 100 125 150 175 0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.085 0.025 0.018 0.026 0.018 0.000 5.50 MAX 2.41 0.15 1.15 0.60 0.89 0.98 MIN 0.217 MAX 0.006 0.095 0.035 0.024 0.045 0.039 4.57 2.29 1.10 1.18 0.51 6.30 0.90 5.02 9.40 6.40 4.70 5.97 10.50 2.10 5.70 5.66 5.00 MIN 2.16 0.64 0.46 0.65 0.46 0.00 0.046 0.020 0.035 0.198 0.252 0.185 0.235 0.370 0.413 0.248 0.083 0.224 0.223 0.043 1.30 1.70 1.00 5.21 5.84 6.50 6.22 6.73 1.25 10.48 10.70 2.30 5.90 5.86 0.051 0.180 0.090 0.067 0.205 0.039 0.230 0.265 0.049 0.245 0.413 0.421 0.256 0.091 0.232 0.231 0.197 19-10-2007 Z8B00003328 derived from
81726 Munich, Germany
81726 München, Germany
© 2008 Infineon Technologies AG All Rights Reserved. Legal Disclaimer The information given in this document shall in no event be regarded as a guarantee of conditions or characteristics. With respect to any examples or hints given herein, any typical values stated herein and/or any information regarding the application of the device, Infineon Technologies hereby disclaims any and all warranties and liabilities of any kind, including without limitation, warranties of non-infringement of intellectual property rights of any third party. Information For further information on technology, delivery terms and conditions and prices, please contact the nearest Infineon Technologies Office (www.infineon.com). Warnings Due to technical requirements, components may contain dangerous substances. For information on the types in question, please contact the nearest Infineon Technologies Office. Infineon Technologies components may be used in life-support devices or systems only with the express written approval of Infineon Technologies, if a failure of such components can reasonably be expected to cause the failure of that life-support device or system or to affect the safety or effectiveness of that device or system. Life support devices or systems are intended to be implanted in the human body or to support and/or maintain and sustain and/or protect human life. If they fail, it is reasonable to assume that the health of the user or other persons may be endangered.